Emisphere Technologies, Inc. (PN) Stock Price - EMIS

Best deals to access real time data!
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Emisphere Technologies, Inc. (PN) EMIS OTC BB Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  +0.0866 +4.16% 2.1665 2.1665 2.05 2.07 2.0799 16:30:10
Bid Price Ask Price Spread Spread % News
2.1 2.17 0.07 3.23% - -
Stock Trades Traded Volume Average Volume 52 Week Range
17 25,815 42.26k 0.25 - 3.09
Last Trade Time Type Quantity Stock Price Currency
15:58:46 100 $2.17 USD

Emisphere Technologies, Inc. (PN) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 136.01M 62.78M $ -20.94M - -6.50 46.14M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Emisphere Technologies, Inc. (PN) News

Real-Time news about Emisphere Technologies, Inc. (PN) (OTCBB): 0 recent articles

Latest EMIS Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical EMIS Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week1.952.181.952.06759k55k22k0.216511.10%
1 Month2.12.181.852.03531k55k17k0.06653.17%
3 Months2.2852.441.722.19601k512k41k-0.1185-5.19%
6 Months2.073.091.722.37151k818k89k0.09654.66%
1 Year0.3853.090.2471.59054542M98k1.7815462.73%
3 Years0.663.090.151.16912402M57k1.5065228.26%
5 Years0.1723.090.00010.87421002M59k1.99451,159.59%

Emisphere Technologies, Inc. (PN) Description

Emisphere is a specialty pharmaceutical company that has recently commenced commercial operations. The Company launched its first prescription product, oral Eligen B12, in the U.S. in March 2015. Beyond Eligen B12, the Company utilizes its proprietary Eligen Technology to create new oral formulations of therapeutic agents. Emisphere is currently partnered with global pharmaceutical companies for the development of new orally delivered therapeutics. For more information, please visit www.emisphere.com.
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V: D:20181119 11:05:46